Blinatumomab improves outcomes for pediatric patients with low-risk B-cell acute lymphoblastic leukemia in first marrow relapse

Transl Pediatr. 2024 Mar 27;13(3):530-534. doi: 10.21037/tp-23-521. Epub 2024 Mar 6.

Authors

Lindsey Murphy¹, Ibrahim Aldoss²

Affiliations

¹ Department of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
² Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA, USA.

No abstract available

Keywords: Acute lymphoblastic leukemia (ALL); blinatumomab; first relapse.

Publication types

Editorial
Comment